NEW ORLEANS — The long-approved antidiabetes therapy metformin may hold promise for reducing the burden of recurrent atrial arrhythmia after catheter ablation in people with overweight or obesity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback